Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair.

FDA approves self-expanding Tendyne TMVR device from Abbott
The self-expanding valve, which gained CE mark approval back in 2020, is available in multiple sizes and can be fully retrieved and repositioned as it is implanted.
Permanent pacemaker implantation after mitral valve surgery: Exploring the impact on long-term survival
PPMI after aortic valve surgery is known to increase certain risks for patients, but its impact after mitral valve procedures is unclear. A team of researchers aimed to learn more, tracking data from more than 4,500 patients.
LVOT modification during robotic mitral valve repair limits complications
While LVOT modification does make these procedures longer, it can help high-risk patients avoid systolic anterior motion.
A super alternative: BATMAN helps cardiologists limit complications during TMVR
The BATMAN technique is a safe, effective way to prevent LVOT obstruction during high-risk transcatheter mitral valve replacement, according to new data presented at SCAI 2025.
Robotic mitral valve repair linked to benefits for elderly patients
Robotic and traditional mitral valve repair surgeries are mostly associated with similar outcomes when treating elderly patients. In some ways, however, robotic procedures may be preferred.

FDA approves self-expanding Tendyne TMVR device from Abbott

The self-expanding valve, which gained CE mark approval back in 2020, is available in multiple sizes and can be fully retrieved and repositioned as it is implanted.

Permanent pacemaker implantation after mitral valve surgery: Exploring the impact on long-term survival

PPMI after aortic valve surgery is known to increase certain risks for patients, but its impact after mitral valve procedures is unclear. A team of researchers aimed to learn more, tracking data from more than 4,500 patients.

LVOT modification during robotic mitral valve repair limits complications

While LVOT modification does make these procedures longer, it can help high-risk patients avoid systolic anterior motion.

A super alternative: BATMAN helps cardiologists limit complications during TMVR

The BATMAN technique is a safe, effective way to prevent LVOT obstruction during high-risk transcatheter mitral valve replacement, according to new data presented at SCAI 2025.

Robotic mitral valve repair linked to benefits for elderly patients

Robotic and traditional mitral valve repair surgeries are mostly associated with similar outcomes when treating elderly patients. In some ways, however, robotic procedures may be preferred.

Edwards Lifesciences announces key approval for new mitral valve replacement system

The Sapien M3 device was designed to treat symptomatic mitral regurgitation in patients who are not suitable candidates for surgery or transcatheter edge-to-edge repair.

Mitral valve repair vs. replacement: Surgeons track long-term outcomes in patients with infective endocarditis

Mitral valve repair was linked to a significant improvement in long-term survival when treating infective endocarditis. Some patients are not good candidates for a repair procedure, however, making replacement the best possible option.

Capstan Medical robotic transcatheter mitral valve replacement

Cardiologists make history, complete world’s first robotic transcatheter mitral valve replacements

One of the cardiologists involved in the procedures said they represent "a significant leap forward in structural heart intervention."